These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36820536)

  • 21. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
    Xi LF; Koutsky LA; Hildesheim A; Galloway DA; Wheeler CM; Winer RL; Ho J; Kiviat NB
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):4-10. PubMed ID: 17220325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
    Kang YJ; Lewis H; Smith MA; Simonella L; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2015 Aug; 15():365. PubMed ID: 26297490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
    Paavonen J; Jenkins D; Bosch FX; Naud P; Salmerón J; Wheeler CM; Chow SN; Apter DL; Kitchener HC; Castellsague X; de Carvalho NS; Skinner SR; Harper DM; Hedrick JA; Jaisamrarn U; Limson GA; Dionne M; Quint W; Spiessens B; Peeters P; Struyf F; Wieting SL; Lehtinen MO; Dubin G;
    Lancet; 2007 Jun; 369(9580):2161-2170. PubMed ID: 17602732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
    Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
    Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of HPV E4 and p16
    Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
    BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
    Eriksen DO; Jensen PT; Schroll JB; Hammer A
    Acta Obstet Gynecol Scand; 2022 Jun; 101(6):597-607. PubMed ID: 35470865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
    Baandrup L; Munk C; Andersen KK; Junge J; Iftner T; Kjær SK
    Gynecol Oncol; 2012 Feb; 124(2):281-5. PubMed ID: 22036987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
    Miralpeix E; Solé-Sedeño JM; Agramunt S; Lloveras B; Gimeno R; Alameda F; Carreras R; Mancebo G
    Int J Gynaecol Obstet; 2019 Oct; 147(1):43-48. PubMed ID: 31272132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
    Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
    Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
    BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
    Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
    Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
    Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
    Wang SS; Zuna RE; Wentzensen N; Dunn ST; Sherman ME; Gold MA; Schiffman M; Wacholder S; Allen RA; Block I; Downing K; Jeronimo J; Carreon JD; Safaeian M; Brown D; Walker JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):113-20. PubMed ID: 19124488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
    PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
    van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
    Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
    Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.